Representative before the EPO

Employment test 51 - 200 employees
Company dna boehmert and boehmert
operating since 1930
Headquarter in Bremen and 13 offices
active in Legal Services and IP Consulting

Representative before the EPO

Company dna forrester and boehmert
operating 1977 - 2012
5 offices
active in Legal Services

Representative before the EPO

Employment test 11 - 50 employees
Company dna forresters
operating since 1884
Headquarter in Birmingham and 7 offices
active in Legal Services and IP Consulting

We have observed 227 EP applications Jonathan Vallance Gowshall has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 20, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12806795

COMPOSITIONS AND METHODS FOR ENHANCED GENERATION OF HEMATOPOIETIC STEM/PROGENITOR CELLS

IPC classification:
A61K 35/12, C12N 5/0789
Applicant:
Novartis Institute for Functional Genomics, Inc.
Applicant:
Fred Hutchinson Cancer Research Center
Applicant:
Novartis AG
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Jones Day
Status:
EXAMINATION IN PROGRESS
EP12855597

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

IPC classification:
A61K 39/42, G01N 33/569, C12N 15/13, C07K 16/10, A61P 31/18
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP12858324

CONTROL AND DELIVERY OF ELECTRIC FIELDS VIA AN ELECTRODE ARRAY

IPC classification:
A61B 18/18
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12880480

BIOCOMPATIBLE METHOD OF FUNCTIONALISING SUBSTRATES WITH INERT SURFACES

IPC classification:
G01N 33/543, G01N 33/53, G01N 33/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12849133

PROCESSES AND SYSTEMS FOR NON-EQUILIBRIUM TRICHLOROSILANE PRODUCTION

IPC classification:
C01B 33/107, B01J 23/755, B01J 23/26, B01J 6/00
Applicant:
SiTec GmbH
Agent:
Multiple attorneys, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14163244

Gene expression profiling in biopsied tumor tissues

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP13738804

TOPICAL THERAPEUTIC FORMULATIONS

IPC classification:
A61K 38/44, A61K 35/12, A61K 31/4422, A61P 19/04, A61P 17/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Pfenning Meinig & Partner GbR
Status:
The patent has been granted
EP13744228

PROMOTING TRANSCRANIAL DIRECT CURRENT STIMULATION OR TRANSCRANIAL MAGNETIC STIMULATION USING TEMPERATURE-INDUCED SYNAPTIC MODULATION

IPC classification:
A61N 2/02, A61N 1/20, A61N 1/04
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13747212

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H3N2, H2N2, AND B INFLUENZA VIRUSES

IPC classification:
A61K 39/145, C12N 15/44, C07K 14/11, A61P 31/16
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13749680

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR HUMAN AND AVIAN H5N1 INFLUENZA

IPC classification:
A61K 39/145, C12N 15/63, C12N 15/44, C07K 14/11, A61P 31/16
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP13713301

SOLUBLE ENGINEERED MONOMERIC FC

IPC classification:
C07K 16/10, C07K 16/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP13763664

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

IPC classification:
A61K 39/42, C07K 16/10, A61P 31/18
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13769077

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H5N1 AND H1N1 INFLUENZA VIRUSES

IPC classification:
A61K 39/145, A61K 31/16, C12N 15/44, C07K 14/11
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP12881774

HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS

IPC classification:
C12Q 1/68
Agent:
Multiple attorneys, Forresters IP LLP
Agent:
Philip Michael Webber, Dehns Ltd
Status:
PATENT GRANTED
EP14195969

Compositions and methods for treating diseases of the nail

IPC classification:
A61K 47/24, A61K 47/14, A61K 47/10, A61K 31/675, A61K 31/454, C07F 9/06
Agent:
Multiple attorneys, Forresters IP LLP
Status:
The patent has been granted
EP13727753

METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES

IPC classification:
A61K 45/06, A61K 31/05, A61P 35/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14185860

Impregnated odour control products and methods of making the same

IPC classification:
A43B 13/12, A43B 1/00, A01N 63/00, A01N 25/34, A01N 25/10, D01F 1/10, C12N 3/00, C12N 1/20, C08K 5/00, A63B 21/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14189399

Mutation in OAS1 genes

IPC classification:
A61K 38/16, C12Q 1/68, C12N 9/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13712625

METHODS AND COMPOSITIONS FOR DETECTION OF LEGIONELLA

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP13713612

CAFFEINE RESPONSIVE PROMOTERS AND REGULATORY GENES

IPC classification:
C12N 15/63
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13806393

METHOD FOR OBTAINING FETAL CELLS AND FETAL CELLULAR COMPONENTS

IPC classification:
A61B 10/02, A61B 10/00, G01N 33/50, C12N 5/073
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13737939

TISSUE-BASED DRAIN MANIFOLDS

IPC classification:
A61M 27/00, A61L 31/04
Applicant:
Lifecell Corporation
Agent:
Multiple attorneys, Forresters IP LLP
Status:
The patent has been granted
EP13745754

MACROPOROUS CATHETER

IPC classification:
A61M 31/00, A61M 27/00, A61M 25/00, A61M 1/28, A61L 29/00, A61B 10/00, A61B 5/145, A61B 5/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13747600

DEPHOSPHORYLATED LYSOSOMAL STORAGE DISEASE PROTEINS AND METHODS OF USE THEREOF

IPC classification:
A61K 47/48, A61K 38/46, C12N 9/16
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13829596

METHODS AND COMPOSITIONS FOR REDUCING GENETIC LIBRARY CONTAMINATION

IPC classification:
C40B 40/08, C40B 40/06, C40B 30/04, C12P 19/34, C07H 21/04
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Philip Michael Webber, Dehns Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13753475

MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF

IPC classification:
A61K 47/48, C07K 16/30
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP13835916

METHODS FOR INCREASING FETAL FRACTION IN MATERNAL BLOOD

IPC classification:
C40B 20/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Philip Michael Webber, Dehns Ltd
Status:
GRANT OF PATENT INTENDED
EP14195468

Methods for non-invasive prenatal ploidy calling

IPC classification:
C12Q 1/68
Agent:
Multiple attorneys, Forresters IP LLP
Status:
PATENT GRANTED
EP13766859

MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY

IPC classification:
A61K 39/395, C07K 16/30, A61P 35/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15158222

Edge coatings for adhesive tapes

IPC classification:
C09J 7/04, C09J 7/02
Agent:
Carrie-Anne Louise Johnson, Barker Brettell LLP
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15152517

Method for using gene expression to determine prognosis of prostate cancer

IPC classification:
G01N 33/574, C12Q 1/68
Agent:
Multiple attorneys, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP15162282

Brachyury polypeptides and methods for use

IPC classification:
A61K 39/00, G01N 33/574, G01N 33/569, C12N 15/113, C07K 14/82, C07K 14/47, C07K 4/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13855449

TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A

IPC classification:
A61K 39/08
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13855135

SURGICAL SYSTEM

IPC classification:
A61B 19/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13857490

INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE

IPC classification:
A61K 38/10, C07K 19/00, C07K 7/08, A61P 37/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13859229

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H1N1 INFLUENZA

IPC classification:
A61K 39/145, A61K 38/16, C12N 15/44, C07K 14/11
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13863944

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

IPC classification:
A61K 39/395
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14737656

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

IPC classification:
C12N 5/0783
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14702339

COMPOSITIONS AND METHODS FOR EXPANSION OF EMBRYONIC HEMATOPOIETIC STEM CELLS

IPC classification:
A61K 35/28, C12N 5/0789
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14740896

ADENOVIRUSES AND THEIR USE

IPC classification:
A61K 39/12, C12Q 1/68, C12P 21/02, C12N 15/861, C12N 15/63, C12N 15/34, C12N 5/10, C07K 16/08, C07K 14/075, A61P 31/20
Applicant:
University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15173816

GENE EXPRESSION MARKERS FOR PREDICTING RESPONSE TO CHEMOTHERAPY

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP15162054

COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER

IPC classification:
A61K 47/14, A61K 45/06, A61K 31/7076, A61K 31/235, A61K 9/48, A61K 9/28, A61K 9/20, A61P 35/00, A61P 29/00, A61P 25/00, A61P 19/02, A61P 1/16
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14706762

COMPOSITIONS AND METHODS FOR TREATING AND REPAIRING TENDONS

IPC classification:
A61K 35/36, C12N 5/0775, C12N 5/077
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14754421

METHODS OF SEQUENCING NUCLEIC ACIDS IN MIXTURES AND COMPOSITIONS RELATED THERETO

IPC classification:
C12N 15/10, C12Q 1/68
Applicant:
Johns Hopkins University
Applicant:
Emory University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15170077

DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES

IPC classification:
C12M 1/12, C12M 1/26, C12N 5/071, C12M 3/00, A61K 35/12, A61K 9/00, A61K 35/34, A61M 1/10
Applicant:
Regents of the University of Minnesota
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14716493

FRAGMENTS OF P97 AND USES THEREOF

IPC classification:
C07K 14/79
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14763713

ACTIVATED CARBON FILTRATION FOR PURIFICATION OF BENZODIAZEPINE ADCs

IPC classification:
C02F 1/28, B01D 15/04, C07D 243/12, A61K 31/55, A01N 43/62, A61K 39/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14778142

CYCLODEXTRIN AND ANTIBODY-DRUG CONJUGATE FORMULATIONS

IPC classification:
C07D 487/00, A61K 39/00, A01N 43/04, C07K 16/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14722428

HYPOSIALYLATION DISORDERS

IPC classification:
G01N 33/68
Applicant:
Emory University
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14763831

ACETYL-COA CARBOXYLASE MUTATIONS

IPC classification:
C12N 1/21, C12N 9/00, C12N 15/52
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14768529

COMPOSITIONS AND METHODS TO MODIFY CELLS FOR THERAPEUTIC OBJECTIVES

IPC classification:
C12N 15/62
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14775224

PREFUSION RSV F PROTEINS AND THEIR USE

IPC classification:
C12N 15/62, C12N 15/45, A61P 43/00, A61K 38/10, A61K 39/155, A61K 39/00, C07K 14/135
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14783418

CHIMERIC ADENO-ASSOCIATED VIRUS/ BOCAVIRUS PARVOVIRUS VECTOR

IPC classification:
A61K 39/23
Applicant:
University of Kansas
Applicant:
University of Iowa Research Foundation
Agent:
Pfizer Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP13881946

DEMOLITION SHEAR AND DEMOLITION SHEAR PIERCING TIP INSERT AND NOSE CONFIGURATION

IPC classification:
B23D 35/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14723540

DEVICES AND METHODS FOR TREATING FUNCTIONAL TRICUSPID VALVE REGURGITATION

IPC classification:
A61F 2/24
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14764077

STEVIA PLANTS WITH AN INCREASED REBAUDIOSIDE D CONTENT

IPC classification:
A01H 5/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14724976

LONE STAR VIRUS

IPC classification:
G01N 33/569, C07K 16/10, C07K 14/175, C12N 7/00
Applicant:
University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14794851

IN SITU MIXING AND APPLICATION OF HYDROCOLLOID SYSTEMS FOR PRE-AND POST HARVEST USE ON AGRICULTURAL CROPS

IPC classification:
A01N 25/00
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14727696

SINGLE-DOMAIN VHH ANTIBODIES DIRECTED TO NOROVIRUS GI.1 AND GII.4 AND THEIR USE

IPC classification:
C07K 16/10, A61P 31/14, A61P 31/12, G01N 33/569, C07K 16/08, A61K 39/395
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP15188264

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
A61K 39/00, G01N 33/68, G01N 33/574, C07K 16/28, A61K 47/48, A61K 39/395, C07K 16/30
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14798331

ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

IPC classification:
C12N 15/86, C12N 15/00, A01N 63/00
Applicant:
Regents of the University of Minnesota
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14728395

COMPOUNDS FOR INHIBITING DRUG-RESISTANT STRAINS OF HIV-1 INTEGRASE

IPC classification:
A61K 45/06, C07D 471/04, A61K 31/5377, A61K 31/496, A61K 31/4704, A61K 31/4375
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14803477

CONOTOXIN PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 38/10
Applicant:
University of Utah Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15195219

METHODS FOR PREPARING COMPLEX MULTIVALENT IMMUNOGENIC CONJUGATES

IPC classification:
A61K 47/48, A61K 39/00, A61K 39/095, A61K 39/08, A61K 39/385
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14735030

ENCIRCLING IMPLANT DELIVERY SYSTEMS AND METHODS

IPC classification:
A61F 2/24
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15199388

SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND USING DATA TO MAKE PREDICTIONS

IPC classification:
G06F 19/24, G06F 19/22, G06F 19/18
Agent:
Richard Gibbs, Marks & Clerk
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14737128

COMPOSITIONS AND METHODS FOR TREATING SKIN

IPC classification:
A61P 17/00, C12N 5/071, A61K 35/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14817352

DEVICES, SYSTEMS AND METHODS FOR MONITORING KNEE REPLACEMENTS

IPC classification:
A61B 5/103, A61B 17/56, A61F 2/46, A61F 2/48, A61F 2/38
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14745037

PHOTOACTIVATABLE LIPID-BASED NANOPARTICLES AS VEHICLES FOR DUAL AGENT DELIVERY

IPC classification:
A61P 35/00, A61K 41/00, A61K 47/48
Applicant:
Baylor College of Medicine
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14745060

HIGH TITER RECOMBINANT INFLUENZA VIRUSES WITH ENHANCED REPLICATION IN MDCK OR VERO CELLS OR EGGS

IPC classification:
C12N 7/00
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13812266

TRANSVASCULAR AND TRANSCAMERAL DEVICE ACCESS AND CLOSURE

IPC classification:
A61B 17/12, A61B 17/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14835867

SWEETENER AND SWEETENED COMPOSITIONS INCORPORATING REBAUDOSIDE N

IPC classification:
C13K 13/00, C07H 15/24, A23L 2/60, A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Myriam Elseviers, Cargill Europe bvba
Status:
GRANT OF PATENT INTENDED
EP15191753

HUMAN FACILITATING CELLS AND USES THEREOF

IPC classification:
A61P 37/00, A61K 35/12, C12N 5/0789, C12N 5/071
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14845828

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS

IPC classification:
A61K 31/18, A61K 31/17, A61K 31/165, C07D 277/62, C07D 263/54, C07D 249/18, C07D 235/04, C07D 213/74, C07D 231/56, C07D 215/02, C07D 209/18, C07C 311/03, C07C 307/10, C07C 275/28, C07C 271/28, C07C 255/00, C07C 237/20, C07C 233/07, C07C 233/11, C07C 235/34
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14845373

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS

IPC classification:
A61P 13/12, A61P 9/12, A61K 31/165, C07C 233/11
Agent:
Multiple attorneys, Forresters IP LLP
Status:
The patent has been granted
EP15202562

BRASSICA PLANTS YIELDING OILS WITH A LOW TOTAL SATURATED FATTY ACID CONTENT

IPC classification:
A01H 5/10, A01H 1/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP14850277

FEED PELLETS AND RELATED SYSTEMS AND METHODS

IPC classification:
A23K 50/15
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Dela Kiadi Matsuela, Cargill Europe bvba
Status:
GRANT OF PATENT INTENDED
EP14790440

DETECTION OF HEPATITIS DELTA VIRUS (HDV) FOR THE DIAGNOSIS AND TREATMENT OF SJÖGREN'S SYNDROME AND LYMPHOMA

IPC classification:
C12Q 1/70, C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14854262

VASCULAR DILATORS

IPC classification:
A61M 25/04, A61M 25/01, A61M 29/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14855615

METHODS OF DETERMINING BREAST CANCER PROGNOSIS

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14858957

METHODS OF INCORPORATION OF TRANSCRIPT CHROMOSOMAL LOCUS INFORMATION FOR IDENTIFICATION OF BIOMARKERS OF DISEASE RECURRENCE RISK

IPC classification:
G06F 19/26
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14855406

ATRIAL APPENDAGE LIGATION

IPC classification:
A61M 25/01, A61B 17/128, A61B 17/12, A61B 17/08, A61B 17/10
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16166924

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
A61K 39/00, G01N 33/68, G01N 33/574, C07K 16/28, A61K 47/48, A61K 39/395, C07K 16/30
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14803025

TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN

IPC classification:
A61P 25/00, A61K 31/00, A61K 38/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14863286

ALLELES MODIFYING BRASSICA PLANT TOTAL SATURATED FATTY ACID CONTENT

IPC classification:
G01N 33/50, G01N 33/48, A01H 5/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14812375

ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE

IPC classification:
C12N 15/86, A61K 48/00, C12N 9/16
Applicant:
University of Florida Research Foundation
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14863650

PREPARING ANTIBODIES FROM CHO CELL CULTURES FOR CONJUGATION

IPC classification:
A61K 47/48, C07K 1/14, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14831120

MULTI-EPITOPE TARP PEPTIDE VACCINE AND USES THEREOF

IPC classification:
A61K 39/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14871434

METHYLENE CARBAMATE LINKERS FOR USE WITH TARGETED-DRUG CONJUGATES

IPC classification:
A61K 47/48
Applicant:
Seattle Genetics, Inc.
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14872462

STABILIZED STEVIOL GLYCOSIDE IN CONCENTRATED SYRUP

IPC classification:
C07D 311/22, A61K 47/36, A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Dela Kiadi Matsuela, Cargill Europe bvba
Status:
EXAMINATION REQUESTED
EP16166020

P97-ANTIBODY CONJUGATES

IPC classification:
C12N 9/14, C07K 16/32, C07K 14/79, A61K 45/06, A61P 35/00, C12N 9/00, A61K 47/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14800182

SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING

IPC classification:
A61K 51/04, C07D 251/68
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16157419

ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS

IPC classification:
A61K 38/00
Applicant:
University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP16162911

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION

IPC classification:
A61P 7/00, A61P 35/02, C07K 16/28, C12N 5/0797, A61K 35/50, A61K 35/44, A61K 35/14
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP16166225

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING

IPC classification:
A61P 35/02, A61P 7/00, C12N 5/0797, C07K 16/28, A61K 35/50, A61K 35/44, A61K 35/14
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16176482

METHOD FOR STERILISING DERMIS

IPC classification:
A61K 35/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15748980

HYDROPHILIC ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 38/08
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15708639

HIV-2 NUCLEIC ACIDS AND METHODS OF DETECTION

IPC classification:
C12Q 1/70, C07K 14/16
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16181799

GENE EXPRESSION PROFILING IN BIOPSIED TUMOR TISSUES

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15758457

EASILY DISPERSIBLE FORMULATIONS OF PIGMENTS AND THEIR USE IN TINTING BASE MEDIA

IPC classification:
C09D 5/02, C09B 67/00, C09C 3/08, C09C 3/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15762002

MULTIPLE PANEL SUTURE DISPENSING CARD AND METHOD FOR USING THE SAME

IPC classification:
A61B 17/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15712513

SYSTEM WITH AN ELECTROMAGNETIC FIELD GENERATOR WITH COILS FOR TREATING TUMORS AND A METHOD FOR TREATING TISSUE

IPC classification:
A61N 2/02, A61N 1/40
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15775944

OPTIMAL DOSING OF A CD19-ANTIBODY DRUG CONJUGATE

IPC classification:
A61K 47/42, C07K 16/28, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15776984

STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 39/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15792704

HIGHLY SOLUBLE STEVIOL GLYCOSIDES

IPC classification:
A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Dela Kiadi Matsuela, Cargill Europe bvba
Status:
EXAMINATION REQUESTED
EP16187573

ANTIBODIES TO ENDOPLASMIN AND THEIR USE

IPC classification:
G01N 33/577, A61K 39/00, C07K 16/18, C12N 15/63, A61K 39/395, G01N 33/574, C12N 15/13, C07K 16/30
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP16195347

METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER

IPC classification:
G01N 33/574, C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15729698

EXPANSION AND ENGRAFTMENT OF STEM CELLS USING NOTCH 1 AND/OR NOTCH 2 AGONISTS

IPC classification:
C12N 5/0789
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15747597

BLOCKING CD38 USING ANTI-CD38 F(AB')2 TO PROTECT NK CELLS

IPC classification:
A61P 37/00, A61P 35/00, C07K 16/28, A61K 39/395
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15727783

LILRB2 AND NOTCH-MEDIATED EXPANSION OF HEMATOPOIETIC PRECURSOR CELLS

IPC classification:
C12N 5/0789
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15812631

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING IMPLANTS

IPC classification:
A61F 2/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15811456

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING HEART VALVES

IPC classification:
A61F 2/24
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15745058

AEROSOL PARTICLE GROWTH SYSTEMS USING POLYMER ELECTROLYTE MEMBRANES

IPC classification:
G01N 15/06
Applicant:
Regents of the University of Minnesota
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16196459

PREDICTION OF LIKELIHOOD OF CANCER RECURRENCE

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15829509

INJECTION DEVICES

IPC classification:
A61M 5/315
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15839012

BOTULINUM TOXIN AND COLLOIDAL SILVER PARTICLES

IPC classification:
A61K 47/02, A61K 33/38, A61K 9/19, A61K 8/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15766697

RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE

IPC classification:
C12N 5/10, C12N 15/49, A61K 39/21, C07K 14/16
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15839347

TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES

IPC classification:
A61K 45/06, C07K 7/02
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15842678

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING MEDICAL DEVICES

IPC classification:
G06F 15/173
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16201265

TISSUE SCAFFOLDS

IPC classification:
A61L 27/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP15849315

METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS

IPC classification:
C07C 33/22, A61P 31/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15787824

SEGMENTED METALLIC GUIDEWIRES

IPC classification:
A61M 25/09
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15790793

DETECTION OF HIV-1 NUCLEIC ACIDS BY REVERSE-TRANSCRIPTION LOOP-MEDIATED ISOTHERMAL AMPLICATION

IPC classification:
C12Q 1/70
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP15856774

USE OF D-RIBOSE TO ENHANCE ADAPTATION TO PHYSICAL STRESS

IPC classification:
A23L 2/52, A23L 2/38, A61K 31/7004
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15798305

TREATMENT OF HORMONAL DISORDERS OF GROWTH

IPC classification:
A61P 5/06, C07K 14/705
Applicant:
Université de Liège
Applicant:
Centre Hospitalier Universitaire de Liège
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15798623

TOPICAL SODIUM NITRITE FORMULATION

IPC classification:
A61K 33/00, A61K 9/06, A61K 47/06, A61K 9/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17162132

VALPROATE AS A TOPICAL ANTI-FUNGAL TREATMENT

IPC classification:
A61K 31/19, A61P 31/10
Applicant:
Wayne State University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP15871082

STEVIOL GLYCOSIDE COMPOUNDS, COMPOSITIONS FOR ORAL INGESTION OR USE, AND METHOD FOR ENHANCING STEVIOL GLYCOSIDE SOLUBILITY

IPC classification:
C07H 15/256, A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Dela Kiadi Matsuela, Cargill Europe bvba
Status:
Request for examination was made
EP15831073

RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE

IPC classification:
C12N 15/09, C07K 14/135, C07K 14/005, A61K 48/00, A61K 39/39, C07K 14/115, A61K 39/155
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15830932

ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF

IPC classification:
C12N 9/00, A61K 38/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17175325

B-CELL ANTIGEN PRESENTING CELL ASSAY

IPC classification:
G01N 33/68
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP16738004

METHODS TO PREVENT OR TREAT PERIODONTITIS OR PERI-IMPLANTITIS

IPC classification:
C12N 5/00, C12N 15/11
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16740786

POINT-OF-CARE AND/OR PORTABLE PLATFORM FOR GENE THERAPY

IPC classification:
C12N 15/85, C12N 15/63, C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16703375

METHODS FOR THE REGENERATION OF ARTICULAR CARTILAGE IN VIVO

IPC classification:
A61P 19/02, A61P 19/00, A61K 38/20, A61K 38/39, A61K 38/19, A61K 38/18
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16749948

COMBINATION THERAPY USING A CD19-ADC AND VINCRISTINE

IPC classification:
A61P 35/02, A61K 39/395, C07K 16/28
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17183578

METHODS FOR PRODUCING AN IMMUNE RESPONSE TO TUBERCULOSIS

IPC classification:
A61K 39/00, G01N 33/569, A61K 49/00, A61K 9/00, A61K 39/385, A61K 38/00, A61K 39/04, A61P 31/06, C12N 15/86, C12N 15/867, A61K 39/39, A61K 38/16
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP16714599

SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS

IPC classification:
A61P 21/00, A61P 9/10, A61P 9/00, A61K 31/7088, A61K 31/702, A61K 31/7012, A61K 45/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17176955

TOPICAL THERAPEUTIC FORMULATIONS

IPC classification:
A61P 19/04, A61P 17/00, A61K 45/06, A61K 9/12, A61K 9/06, A61K 9/00, A61K 35/12, A61K 38/44, A61K 31/277, A61K 31/40, A61K 31/4422, A61K 31/554
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP16765773

CD48 ANTIBODIES AND CONJUGATES THEREOF

IPC classification:
C07K 16/28, C07K 16/18, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16716979

NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE

IPC classification:
A61P 31/18, C07K 16/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16769681

ENGINEERED AND MULTIMERIZED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEINS AND USES THEREOF

IPC classification:
C12N 15/63, C12N 15/49, C12N 15/00, C07K 14/155, A61K 39/21
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17185795

IMPLANTABLE PROSTHESIS HAVING ACELLULAR TISSUE ATTACHMENTS

IPC classification:
A61B 90/00, A61F 2/00, A61F 2/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP17194586

ELASTASE TREATMENT OF TISSUE MATRICES

IPC classification:
A61L 27/36
Applicant:
Lifecell Corporation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16196935

N-ACETYL MANNOSAMINE FOR THE TREATMENT OF A KIDNEY-DISEASE

IPC classification:
A61P 21/00, A61P 13/12, A61K 31/7008
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16797013

ADENO-ASSOCIATED FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM

IPC classification:
C12N 15/86, C12N 7/00, A61K 38/47
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16796939

THREE-DIMENSIONAL RIGHT ATRIAL APPENDAGE CURVE CATHETER

IPC classification:
A61B 18/00, A61B 17/00, A61M 25/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16797397

GLYCOSIDE COMPOSITIONS

IPC classification:
A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Cass A.C. Dottridge, Cargill Europe bvba
Status:
Request for examination was made
EP16804170

FERMENTATION METHODS FOR PRODUCING STEVIOL GLYCOSIDES WITH MULTI-PHASE FEEDING

IPC classification:
C12N 1/21, C12N 1/19, C12N 1/15
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16804137

FERMENTATION METHODS FOR PRODUCING STEVIOL GLYCOSIDES USING HIGH PH AND COMPOSITIONS OBTAINED THEREFROM

IPC classification:
C12P 19/00, C12N 1/19
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16804152

HEAT TREATMENT TO PRODUCE GLYCOSIDES

IPC classification:
C12P 19/56, A61K 31/70, A23L 2/60
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17203380

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR HUMAN AND AVIAN H5N1 INFLUENZA

IPC classification:
C12N 15/63, C12N 15/44, A61P 31/16, A61K 39/145, C07K 14/11
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Examination is in progress
EP16808263

CD123 ANTIBODIES AND CONJUGATES THEREOF

IPC classification:
C07K 16/28, A61K 47/48, A61K 39/395, A61K 31/5517, A61K 31/5513
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17205518

MODULATION OF REPLICATIVE FITNESS BY USING LESS FREQUENTLY USED SYNONYMOUS CODONS

IPC classification:
C07K 14/245, C12N 15/67, A61K 39/108, C12N 7/00, A61K 39/00, C12N 5/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16739339

METHODS OF CHARACTERIZING ADRENOCORTICAL TUMORS

IPC classification:
G01N 33/68, G01N 33/574
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16818762

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

IPC classification:
A61P 35/00, C07K 16/28, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17192980

P97 FRAGMENTS WITH TRANSFER ACTIVITY

IPC classification:
C07K 16/18, A61K 39/44, A61K 39/395, A61K 38/17, A61K 38/00, A61K 38/40, C07K 14/79
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP17210125

REGENERATIVE TISSUE SCAFFOLDS

IPC classification:
A61L 27/50, A61L 27/48
Applicant:
Lifecell Corporation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17197785

METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)

IPC classification:
C12N 5/074, C12N 5/079
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP17210140

MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF

IPC classification:
C12N 5/0783, A61K 39/395, C07K 16/30
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18154204

PROCESSED ADIPOSE TISSUE

IPC classification:
A61L 27/36
Applicant:
Lifecell Corporation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16757452

PREVENTATIVE THERAPY FOR POST-TRAUMATIC OSTEOARTHRITIS

IPC classification:
A61K 31/515, A61K 47/36, A61K 47/34, A61K 9/06, A61K 9/00, A61L 27/54, A61L 27/52, A61L 27/50, A61L 27/26
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16751139

METHOD AND DEVICE FOR DETECTING ANTIGEN-SPECIFIC ANTIBODIES IN A BIOLOGICAL FLUID SAMPLE BY USING NEODYMIUM MAGNETS

IPC classification:
G01N 33/58, G01N 33/566, G01N 33/543
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16767117

SYSTEMS AND METHODS FOR A PORTABLE REAL TIME IN-SITU GAMMA RAY ANALYSIS

IPC classification:
G01T 7/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16766444

METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS

IPC classification:
C12N 5/079
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16775023

EXPRESSION VECTOR DELIVERY SYSTEM AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE

IPC classification:
A61K 39/39
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
The Chancellor, Masters and Scholars of the University of Oxford
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18160345

PREPARATION OF REGENERATIVE TISSUE SCAFFOLDS

IPC classification:
A61F 2/00, A61L 27/48, A61L 27/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16847168

SEGMENTED MRI CATHETERS AND OTHER INTERVENTIONAL DEVICES

IPC classification:
A61B 5/00, A61B 5/055
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16774745

CANCER DETECTION METHODS

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16778536

MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE

IPC classification:
C07K 16/28
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18160105

HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF

IPC classification:
A61K 39/12, G01N 33/68, C07K 16/10, C07K 14/08, C12N 15/40, C12N 7/01
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
ABG Intellectual Property, S.L.
Agent:
ABG Patentes SL
Status:
Request for examination was made
EP16852621

ALIGNMENT ANGLE SENSOR SYSTEMS FOR LIMB PROSTHESES

IPC classification:
A61F 2/76
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16852768

ENDO-CAMERAL CLOSURE DEVICE

IPC classification:
A61M 25/01, A61B 17/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18162110

METHODS FOR DETECTING A MYCOBACTERIUM TUBERCULOSIS INFECTION

IPC classification:
A61K 9/00, A61K 39/00, G01N 33/569, A61K 49/00, A61K 39/385, A61K 38/00, A61K 39/04, A61P 31/06, C12N 15/86, C12N 15/867, A61K 39/39, A61K 38/16
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16778630

HUMAN ROTA VIRUS G9P[6]STRAIN AND USE AS A VACCINE

IPC classification:
C12N 7/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16784678

IL-7R-ALPHA SPECIFIC ANTIBODIES FOR TREATING ACUTE LYMPHOBLASTIC LEUKEMIA

IPC classification:
A61P 35/02, A61P 37/00, A61K 39/395, C07K 16/28
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16794111

CODON-OPTIMIZED REDUCED-SIZE ATP7A CDNA AND USES FOR TREATMENT OF COPPER TRANSPORT DISORDERS

IPC classification:
C12N 9/14
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16757441

VIOLOGEN-FUNCTIONALIZED PORPHYRINS FOR REDUCING BIOFOULING ON SURFACES

IPC classification:
C07F 3/02, C07D 487/22, C07F 15/02, A61L 31/08, A61L 29/08, A61L 27/28, C07F 13/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16795498

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS

IPC classification:
A61K 39/00
Applicant:
Baylor College of Medicine
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16854326

MICROFLUIDIC TISSUE DEVELOPMENT SYSTEMS

IPC classification:
C12M 1/32, C12M 1/20, C12M 1/00, C12M 3/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16801639

NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE

IPC classification:
C07K 16/10
Applicant:
Columbia University in the City of New York
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16871428

STEVIOL GLYCOSIDE COMPOSITIONS FOR ORAL INGESTION OR USE

IPC classification:
A23L 2/60, A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16822321

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES

IPC classification:
C12N 7/04, C07K 14/005, A61K 39/155
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16838103

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS

IPC classification:
A61K 39/155, C12N 5/10, C12N 15/45, C12N 7/04
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18173830

METHODS OF MANUFACTURING BREAST PROSTHESES

IPC classification:
A61F 2/12, A61F 2/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17706618

GENE SIGNATURE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE)

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17712275

PEPTIDE VACCINES COMPRISING SELF-ASSEMBLING POLYMER NANOPARTICLES

IPC classification:
A61K 39/39, A61K 39/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17712339

AAV-MEDIATED EXPRESSION USING A SYNTHETIC PROMOTER AND ENHANCER

IPC classification:
A61K 48/00, C12N 15/86
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17764249

METHODS AND COMPOSITIONS FOR TREATING TUMORS

IPC classification:
C07K 16/28, A61K 38/46, A61K 39/395
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17714066

LIVE ATTENUATED ZIKA VIRUS VACCINE

IPC classification:
A61K 39/12
Applicant:
Johns Hopkins University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18188577

NEW HUMAN ROTAVIRUS STRAINS AND VACCINES

IPC classification:
A61P 37/00, A61K 38/16, A61K 39/39, A61K 39/42, A61K 39/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17712642

RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE

IPC classification:
C07K 14/005, A61K 39/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18190538

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

IPC classification:
C12N 15/63, C12N 15/44, C12N 15/33, A61K 39/145
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17767448

COMBINATION THERAPY USING A LIV1-ADC AND A CHEMOTHERAPEUTIC

IPC classification:
C07K 16/30, A61K 47/55, A61K 47/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17771204

IMPLANTABLE REPORTING PROCESSOR FOR AN ALERT IMPLANT

IPC classification:
A61B 5/103, A61B 5/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18195811

ABDOMINAL WALL TREATMENT DEVICES

IPC classification:
A61F 13/00, A61B 17/08
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17720590

SUBSTITUTIONS-MODIFIED PREFUSION RSV F PROTEINS AND THEIR USE

IPC classification:
A61K 39/00, A61P 31/14, C07K 14/005, A61K 39/155, A61K 39/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17721893

FRANCISELLA LIPIDS AS BROAD ANTI-INFLAMMATORY THERAPEUTICS AND ASSOCIATED METHODS OF USE

IPC classification:
A61K 39/02, C12N 1/20
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18196228

ACTIVATED CARBON FILTRATION FOR PURIFICATION OF BENZODIAZEPINE ADCS

IPC classification:
C07D 519/00, C07K 16/28, C07K 16/00, C07K 1/34, C02F 1/28, C07D 487/04, C07D 243/12, A61K 47/68, B01D 15/08, B01D 15/04, A01N 43/62, A61K 39/00, A61K 31/5517, A61K 31/55
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18186594

ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE

IPC classification:
C12N 15/86, A61K 48/00, C12N 9/16
Applicant:
University of Florida Research Foundation
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP17800268

REDUCED OXYGEN CARRIERS AND THEIR USE FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA

IPC classification:
C07K 14/795, C01C 3/08, C01B 32/40, A61K 38/42, A61K 35/14, A61K 31/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18206583

ELONGATED TISSUE MATRICES

IPC classification:
A61L 27/38, A61L 27/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP18191527

METHODS FOR ISOLATING NON-BULBAR DERMAL SHEATH CELLS AND COMPOSITIONS

IPC classification:
A61K 38/18, A61K 35/36, C12N 5/0775, C12N 5/077
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP17810897

EYEOPENER

IPC classification:
A61H 35/02, A61H 33/04, A61H 33/00, B65D 37/00, A61F 9/00, A61F 9/007
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17733670

NUCLEIC ACIDS ENCODING ZIKA VIRUS-LIKE PARTICLES AND THEIR USE IN ZIKA VIRUS VACCINES AND DIAGNOSTIC ASSAYS

IPC classification:
C07K 14/005, A61K 39/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18190058

PREDICTION OF LIKELIHOOD OF CANCER RECURRENCE

IPC classification:
C12Q 1/6886
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP18209569

METHOD FOR ENZYMATIC TREATMENT OF TISSUE PRODUCTS

IPC classification:
A61L 27/56, A61L 27/24
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP17758969

SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES FOR DISPLAY OF CO-ASSEMBLED TRIMERIC ANTIGENS

IPC classification:
C07K 14/435, C07K 14/16, C07K 14/11, A61K 39/295, A61K 39/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17742333

HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE

IPC classification:
C07K 14/47, C07K 14/005, C12N 15/85, A61K 35/17, C07K 14/725
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17740574

CHIMERIC DENGUE/ZIKA VIRUSES LIVE-ATTENUATED ZIKA VIRUS VACCINES

IPC classification:
A61K 39/12, C12N 7/00, C07K 14/005
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17757972

SELECTIVE ESTROGEN-RECEPTOR MODULATORS (SERMS) CONFER PROTECTION AGAINST PHOTORECEPTOR DEGENERATION

IPC classification:
A61P 27/02, A61K 31/55, A61K 31/4535, A61K 31/138
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17828588

MULTIPLE BI-SPECIFIC BINDING DOMAIN CONSTRUCTS WITH DIFFERENT EPITOPE BINDING TO TREAT CANCER

IPC classification:
C12N 15/09, C07K 16/28, A61K 39/395
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17754517

METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE

IPC classification:
C12N 5/0783
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17831933

COMBINATION THERAPY USING A CD19-ADC AND RCHP

IPC classification:
A61K 31/70, A61K 39/395, A61K 39/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17837576

ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS EXPRESSING IMMUNE SYSTEM-STIMULATORY MOLECULES

IPC classification:
C12N 15/869, C07K 14/54, C07K 14/035, A61K 38/20, A61K 38/17
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17837478

HUMAN INDUCED PLURIPOTENT STEM CELLS FOR HIGH EFFICIENCY GENETIC ENGINEERING

IPC classification:
C12N 5/10, C12N 15/113
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17746316

MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF

IPC classification:
A61K 39/00, A61P 35/00, A61K 47/68, C12N 15/113, C07K 16/30, C07K 16/18
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP18210458

FLOWABLE TISSUE PRODUCTS

IPC classification:
A61L 27/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP17849668

GLAUCOMA TREATMENT METHODS AND APPARATUS

IPC classification:
A61N 1/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17851582

GENETICALLY MODIFIED LACTATE-CONSUMING YEASTS AND FERMENTATION PROCESSES USING SUCH GENETICALLY MODIFIED YEASTS

IPC classification:
C12N 9/04
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17778069

CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE

IPC classification:
C07K 16/28, A61K 39/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17853753

HARNESSING PROTEIN-BASED DRUGS COMPRISING AN ANCHOR DOMAIN FOR USE ON THE OCULAR SURFACE

IPC classification:
A61P 27/02, A61K 39/395, A61K 38/56, C12N 15/62
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP19158081

DECELLULARIZED MUSCLE MATRIX

IPC classification:
A61F 2/08, A61K 35/34, A61L 27/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP17800655

PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE

IPC classification:
A61K 39/12
Applicant:
Trustees of Dartmouth College
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17868307

COMBINATION THERAPY FOR TREATMENT OF BRAIN CANCERS

IPC classification:
C12N 7/00, A61K 9/00, C12N 15/861, A61K 35/76
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17866605

DISTRIBUTION OF ENGINEERED-CYSTEINE CAPS

IPC classification:
C12N 15/09, C07K 16/28, C07K 16/00, A61K 51/10, A61K 47/50, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17801270

3D VASCULARIZED HUMAN OCULAR TISSUE FOR CELL THERAPY AND DRUG DISCOVERY

IPC classification:
A61L 27/58, A61L 27/56, A61L 27/52, A61L 27/38, A61L 27/24, A61L 27/18
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17801272

TISSUE CLAMP AND IMPLANTATION METHOD

IPC classification:
A61B 17/122, A61B 17/04, A61B 17/08, A61F 9/007
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made

Please Sign in to use this feature